Physician profile
James Ryan Mark
NPI 1336382027
$31,907.37
in general payments reported to CMS, 2019-2025
24 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $450 · 2021: $59.18 · 2022: $1,220 · 2023: $6,190 · 2024: $23K · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $2,827 · Travel and Lodging: $2,557 · Honoraria: $83.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,106.35 |
| Food and Beverage | $2,826.76 |
| Travel and Lodging | $2,557.04 |
| Honoraria | $83.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $28,297.64 | 2022-2024 | Da Vinci Surgical System |
| Angiodynamics, INC. | $1,548.32 | 2023 | Nanoknife |
| Merck Sharp & Dohme LLC | $919.02 | 2019-2023 | Keytruda, Lynparza |
| Astellas Pharma US INC | $209.63 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Myriad Genetic Laboratories, INC. | $159.99 | 2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $150.71 | 2019-2025 | |
| Janssen Biotech, INC. | $135.15 | 2023-2025 | Rybrevant, Carvykti, Erleada |
| C. R. Bard, INC. & Subsidiaries | $83.00 | 2024 | |
| Dentsply Ih Ab | $43.75 | 2025 | Lofric |
| Photocure INC | $41.67 | 2022 | |
| Abbvie INC. | $39.96 | 2021-2024 | |
| Smith+Nephew, INC. | $34.98 | 2025 | Grafix Pl, Stravix Pl |
| Urogen Pharma, INC. | $33.52 | 2025 | |
| Convatec INC. | $31.23 | 2022 | |
| Abc Home Medical Supply, INC. | $30.19 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.52 | 2024 | Ta, Surgisleeve |
| Civco Medical Instruments | $27.25 | 2025 | |
| Telix Pharmaceuticals | $24.59 | 2023 | Illuccix |
| Boston Scientific Corporation | $19.65 | 2024 | Spaceoar Vue System - 10ml |
| Myovant Sciences INC. | $17.05 | 2022 | |
| Sumitomo Pharma America, INC. | $16.55 | 2023 | Orgovyx |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.